Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV [Yahoo! Finance]
Evotec SE (EVO)
NASDAQ:AMEX Investor Relations:
eatonvance.com
Company Research
Source: Yahoo! Finance
AGREEMENT BUILDS ON PREVIOUS NIAID-FUNDED COLLABORATION TO DEVELOP A BROADLY NEUTRALISING ANTIBODY AGAINST HIV HAMBURG, GERMANY / ACCESSWIRE / February 7, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today announced that its Seattle-based subsidiary Just - Evotec Biologics, Inc. has expanded its relationship with Advanced BioScience Laboratories, Inc. ("ABL"), a global contract development and manufacturing organisation ("CDMO") serving the US Government and biopharmaceutical industry. The expansion is under a new contract funded entirely by Federal funds under an indefinite delivery/indefinite quantity ("IDIQ") contract awarded to ABL from National Institute of Allergy and Infectious Disease ("NIAID"), National Institutes of Health ("NIH"), Department of Health and Human Services, ("DHHS") under Contract No. HHSN272201700010I/ 75N93023F00001. The new agreement builds on previous collaborations between Just - Evotec Biologics and A
Show less
Read more
Impact Snapshot
Event Time:
EVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVO alerts
High impacting Evotec SE news events
Weekly update
A roundup of the hottest topics
EVO
News
- Bayer and Evotec Collaborate to Advance Precision Cardiology [Yahoo! Finance]Yahoo! Finance
- Bayer and Evotec Collaborate to Advance Precision CardiologyAccesswire
- Evotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Evotec SE (NASDAQ: EVO) had its price target lowered by analysts at HC Wainwright from $14.00 to $11.00. They now have a "buy" rating on the stock.MarketBeat
- Evotec: Still A Speculative Buy After A Significant Decline [Seeking Alpha]Seeking Alpha